My Quote Request
No products added yet
6505-01-270-5090
20 Products
PARAFLEX TABLETS
CHLORZOXAZONE TABLETS,USP
NSN, MFG P/N
6505012705090
NSN
6505-01-270-5090
PARAFLEX TABLETS
CHLORZOXAZONE TABLETS,USP
NSN, MFG P/N
6505012705090
NSN
6505-01-270-5090
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS CHLORZOXAZONE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: SCORED; PEACH; ROUND
Related Searches:
NDC00087-0734-41
ENCAINIDE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505012699173
NSN
6505-01-269-9173
NDC00087-0734-41
ENCAINIDE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505012699173
NSN
6505-01-269-9173
MFG
MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.1022 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 12
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 1.43 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.0085 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.1192 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 35.000 MILLIGRAMS ENCAINIDE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
0735-01
ENCAINIDE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505012699174
NSN
6505-01-269-9174
0735-01
ENCAINIDE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505012699174
NSN
6505-01-269-9174
MFG
MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.1205 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 12
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 1.85 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.0100 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.1542 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS ENCAINIDE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
ENKAID
ENCAINIDE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505012699174
NSN
6505-01-269-9174
ENKAID
ENCAINIDE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505012699174
NSN
6505-01-269-9174
MFG
MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.1205 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 12
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 1.85 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.0100 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.1542 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS ENCAINIDE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
ENKAID CAPSULES
ENCAINIDE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505012699174
NSN
6505-01-269-9174
ENKAID CAPSULES
ENCAINIDE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505012699174
NSN
6505-01-269-9174
MFG
MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.1205 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 12
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 1.85 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.0100 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.1542 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS ENCAINIDE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00087-0735-41
ENCAINIDE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505012699174
NSN
6505-01-269-9174
NDC00087-0735-41
ENCAINIDE HYDROCHLORIDE CAPSULES
NSN, MFG P/N
6505012699174
NSN
6505-01-269-9174
MFG
MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.1205 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 12
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 1.85 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.0100 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.1542 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS ENCAINIDE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00332-3147-13
CEPHALEXIN CAPSULES,USP
NSN, MFG P/N
6505012699179
NSN
6505-01-269-9179
NDC00332-3147-13
CEPHALEXIN CAPSULES,USP
NSN, MFG P/N
6505012699179
NSN
6505-01-269-9179
MFG
BIOCRAFT LABORATORIES INC CORPORATE HQ
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS CEPHALEXIN ACTIVE INGREDIENT
ADMINISTRATION: ORAL
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 500.000
CAPSULE TYPE: SOFT
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00555-0515-04
CEPHALEXIN CAPSULES,USP
NSN, MFG P/N
6505012699179
NSN
6505-01-269-9179
NDC00555-0515-04
CEPHALEXIN CAPSULES,USP
NSN, MFG P/N
6505012699179
NSN
6505-01-269-9179
MFG
BARR PHARMACEUTICALS LLC
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS CEPHALEXIN ACTIVE INGREDIENT
ADMINISTRATION: ORAL
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 500.000
CAPSULE TYPE: SOFT
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
KEFUROX
CEFUROXIME SODIUM,USP
NSN, MFG P/N
6505012700399
NSN
6505-01-270-0399
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 750.000 MILLIGRAMS CEFUROXIME EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFUROXIME SODIUM STERILE POWDER FORM 750MG VIAL 25S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 750.000 MILLIGRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: IN 18 ML CAPACITY GLASS VIAL WITH DOUBLED LEAD SCREW THREAD TO INTERLOCK WITH INLET PORT OF DEXTROSE INJECTION; 6505-01-260-1237; 6505-01-260-1238; 6505-01-260-1239 AND SODIUM CHLORIDE INJECTION; 6505-01-260-1241; 6505-01-260-1242; AND 6505-01-260-6715;
TOTAL PRIMARY CONTAINER QUANTITY: 25
~1: EACH VIAL SHALL BE ENCLOSED IN AN UPPER AND LOWER PLASTIC SHROUD
Related Searches:
KEFUROX ADD-VANTAGE
CEFUROXIME SODIUM,USP
NSN, MFG P/N
6505012700399
NSN
6505-01-270-0399
KEFUROX ADD-VANTAGE
CEFUROXIME SODIUM,USP
NSN, MFG P/N
6505012700399
NSN
6505-01-270-0399
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 750.000 MILLIGRAMS CEFUROXIME EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFUROXIME SODIUM STERILE POWDER FORM 750MG VIAL 25S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 750.000 MILLIGRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: IN 18 ML CAPACITY GLASS VIAL WITH DOUBLED LEAD SCREW THREAD TO INTERLOCK WITH INLET PORT OF DEXTROSE INJECTION; 6505-01-260-1237; 6505-01-260-1238; 6505-01-260-1239 AND SODIUM CHLORIDE INJECTION; 6505-01-260-1241; 6505-01-260-1242; AND 6505-01-260-6715;
TOTAL PRIMARY CONTAINER QUANTITY: 25
~1: EACH VIAL SHALL BE ENCLOSED IN AN UPPER AND LOWER PLASTIC SHROUD
Related Searches:
NDC00002-7278-25
CEFUROXIME SODIUM,USP
NSN, MFG P/N
6505012700399
NSN
6505-01-270-0399
NDC00002-7278-25
CEFUROXIME SODIUM,USP
NSN, MFG P/N
6505012700399
NSN
6505-01-270-0399
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 750.000 MILLIGRAMS CEFUROXIME EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFUROXIME SODIUM STERILE POWDER FORM 750MG VIAL 25S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 750.000 MILLIGRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: IN 18 ML CAPACITY GLASS VIAL WITH DOUBLED LEAD SCREW THREAD TO INTERLOCK WITH INLET PORT OF DEXTROSE INJECTION; 6505-01-260-1237; 6505-01-260-1238; 6505-01-260-1239 AND SODIUM CHLORIDE INJECTION; 6505-01-260-1241; 6505-01-260-1242; AND 6505-01-260-6715;
TOTAL PRIMARY CONTAINER QUANTITY: 25
~1: EACH VIAL SHALL BE ENCLOSED IN AN UPPER AND LOWER PLASTIC SHROUD
Related Searches:
NDC10592-0001-01
EMOLLIENT OIL,NASAL
NSN, MFG P/N
6505012701511
NSN
6505-01-270-1511
MFG
JAMOL LABORATORIES INC
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: CONTAINS OILS OF CAJEPUT,EUCALYPTUS,AND PEPPERMINT IN IODIZED COTTONSEED OIL; 0.6 PCT. TOTAL IODINE; 30 ML OR 1.0 FL OZ BOTTLE W/DROPPER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: EMOLLIENT OIL NASAL 30ML DROPPER BOTTLE
Related Searches:
PONARIS
EMOLLIENT OIL,NASAL
NSN, MFG P/N
6505012701511
NSN
6505-01-270-1511
MFG
JAMOL LABORATORIES INC
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: CONTAINS OILS OF CAJEPUT,EUCALYPTUS,AND PEPPERMINT IN IODIZED COTTONSEED OIL; 0.6 PCT. TOTAL IODINE; 30 ML OR 1.0 FL OZ BOTTLE W/DROPPER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: EMOLLIENT OIL NASAL 30ML DROPPER BOTTLE
Related Searches:
1901
MORPHINE SULFATE INJECTION,USP
NSN, MFG P/N
6505012701554
NSN
6505-01-270-1554
MFG
INTERNATIONAL MEDICATION SYSTEMS LTD.
Description
ADMINISTRATION: INTRAVENOUS INFUSION
FEATURES PROVIDED: STERILE
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE-NEEDLE UNIT
SPECIAL FEATURES: NEEDLE SIZE 21 GAGE BY 1-1/2 INCHES
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00548-1901-00
MORPHINE SULFATE INJECTION,USP
NSN, MFG P/N
6505012701554
NSN
6505-01-270-1554
NDC00548-1901-00
MORPHINE SULFATE INJECTION,USP
NSN, MFG P/N
6505012701554
NSN
6505-01-270-1554
MFG
INTERNATIONAL MEDICATION SYSTEMS LTD.
Description
ADMINISTRATION: INTRAVENOUS INFUSION
FEATURES PROVIDED: STERILE
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE-NEEDLE UNIT
SPECIAL FEATURES: NEEDLE SIZE 21 GAGE BY 1-1/2 INCHES
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
000317
GENTAMICIN SULFATE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505012701555
NSN
6505-01-270-1555
000317
GENTAMICIN SULFATE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505012701555
NSN
6505-01-270-1555
MFG
ALLERGAN INC
Description
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC SQUEEZE
Related Searches:
GENOPTIC OPHTHALMIC SOLUTION
GENTAMICIN SULFATE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505012701555
NSN
6505-01-270-1555
GENOPTIC OPHTHALMIC SOLUTION
GENTAMICIN SULFATE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505012701555
NSN
6505-01-270-1555
MFG
ALLERGAN INC
Description
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC SQUEEZE
Related Searches:
NDC00023-0117-01
GENTAMICIN SULFATE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505012701555
NSN
6505-01-270-1555
NDC00023-0117-01
GENTAMICIN SULFATE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505012701555
NSN
6505-01-270-1555
MFG
ALLERGAN INC
Description
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC SQUEEZE
Related Searches:
624-2446-001
CYLINDER,SULFUR HEX
NSN, MFG P/N
6505012703149
NSN
6505-01-270-3149
MFG
ROCKWELL COLLINS INC. DBA GOVERNMENT SYSTEMS DIV GOVERNMENT SYSTEMS
Description
CYLINDER,SULFUR HEX
Related Searches:
NDC00182-1780-01
CHLORZOXAZONE TABLETS,USP
NSN, MFG P/N
6505012705090
NSN
6505-01-270-5090
NDC00182-1780-01
CHLORZOXAZONE TABLETS,USP
NSN, MFG P/N
6505012705090
NSN
6505-01-270-5090
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS CHLORZOXAZONE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: SCORED; PEACH; ROUND
